Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Controlling drug design through ‘unnatural’ selection

12.12.2006
Darwin probably never envisaged that, 150 years after ‘Origin of the Species’ was published, scientists would be adapting his ideas to improve drug design, but new research from the University of Leeds is doing just that.

Enzymologist Alan Berry and chemist Adam Nelson used ‘directed evolution’ to adapt a natural enzyme to make analogues of the anti-flu drug, Relenza™. The scientists – from Leeds’ Astbury Centre – created enzymes able to control the three-dimensional construction of the drug-like molecules they produced. Controlling the shape of drugs at this level is essential since many therapeutics only work when in one format and, in some cases – such as Thalidomide – the wrong format can have serious side effects. This is the first time that the technique has been used in this way.

Directed evolution mirrors natural evolution, except that the researchers control which properties are passed on to the next ‘generation’. Dr Berry and Professor Nelson made thousands of copies of their target enzyme, each subtly different to the ‘parent’, and then selected the ones that suited their purpose best. They then repeated the process, until, step by step, they had the final enzymes they were looking for.

Dr Berry said: “Enzymes can be engineered using rational design, but it takes a lot of time to amass enough information to use that approach. With directed evolution, you pick randomly from a huge number of copies of the enzyme to find the properties you want. It’s fully automated and very high throughput. Syntheses of anti-flu drugs are complicated, but using this technique you can cut out some of the process – often generating enzymes which are much more efficient than their natural ‘parents’.”

... more about:
»Design »enzyme

Professor Nelson said: “Directed evolution could help simplify the production process for many drugs already on the market, but it’s unlikely to be used in this way as a new method of synthesis requires approval even for an existing drug. However, in the future, drug design is likely to focus more and more on directed evolution, with a big increase in the number of bio-engineered catalysts created for drug development.”

Dr Berry added: “It is surprising that chemical manufacturers don’t use enzymes more widely as catalysts, as they are environmentally friendly. The main stumbling block has been that enzymes will only carry out very specific reactions. However, we’ve shown that directed evolution allows us to modify natural enzymes as required, opening up the possibility of creating tailored catalysts for a range of industrial chemical syntheses.”

The research was funded by the BBSRC, EPSRC and the Wellcome Trust. The scientists have secured further funding from these agencies to look at adapting enzymes to create more complex sugars, such as di- and tri-saccharides.

Abigail Chard | alfa
Further information:
http://www.chem.leeds.ac.uk

Further reports about: Design enzyme

More articles from Life Sciences:

nachricht Embryonic development: How do limbs develop from cells?
18.05.2018 | Humboldt-Universität zu Berlin

nachricht Reading histone modifications, an oncoprotein is modified in return
18.05.2018 | American Society for Biochemistry and Molecular Biology

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

Im Focus: Computer-Designed Customized Regenerative Heart Valves

Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...

Im Focus: Light-induced superconductivity under high pressure

A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.

Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Supersonic waves may help electronics beat the heat

18.05.2018 | Power and Electrical Engineering

Keeping a Close Eye on Ice Loss

18.05.2018 | Information Technology

CrowdWater: An App for Flood Research

18.05.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>